The ‘How Much’ & ‘How To’ guide to EVOO

The ‘How Much’ & ‘How To’ guide to EVOO

The ‘How Much’ & ‘How To’ guide to EVOO

Extra virgin olive oil (EVOO) is a unique source of dietary fat, consisting mainly of monounsaturated fatty acids and bioactive compounds. While oleic acid, the main fatty acid in olive oil, is considered to offer a host of beneficial effects such as lowering the risk of cardiovascular disease, other bioactive compounds such as polyphenols enhance the health-promoting effects offered by olive oil.1 This specific profile of EVOO is what leads to the health benefits associated with it.

EVOO should be included as a food in your daily eating pattern and not as a medicine! It is important to keep in mind that the beneficial effects of the Mediterranean eating pattern are not attributed to a single food or nutrient. Rather, it is how all the key foods, and nutrients of these foods, work together to bring about the plethora of health benefits associated with this eating pattern.2 This is due to a synergistic effect between foods. For example, olive oil assists with absorbing fat-soluble vitamins found in colourful fruits and vegetables. EVOO also increases the palatability and appeal of vegetables and legumes (key elements of the Mediterranean Diet), encouraging their consumption.

How much

Evidence from a number of clinical trials indicates that we should aim to consume at least 25 ml (approximately 2 tablespoons) of EVOO per day, to obtain the health benefits associated with it, in healthy populations and those with risk factors such as mild dyslipidemia and mild hypertension.3  

In terms of following a therapeutic Mediterranean eating pattern, there doesn’t seem to be a clear definition of how much EVOO should be included.4 However, the PREDIMED (Prevention with Mediterranean Diet) trial implemented a minimum quantity of 60 ml (4 tablespoons) of EVOO a day. This study was a primary prevention trial, which evaluated the effects of the Mediterranean Diet on incident cardiovascular disease in men and women at high risk.5 Furthermore, a different study, the AUSMED (Australian Mediterranean Diet) Heart Trial implemented 60 – 80 ml (4 – 5 tablespoons) of EVOO a day.6 

Based on the reduction in risk seen in these and other trials, it is recommended that a minimum of 3 – 4 tablespoons of EVOO should be consumed per day for pre-existing health conditions including Coronary Heart Disease, Type 2 Diabetes, and Fatty Liver Disease.7 

Due to the substantial evidence supporting the health effects of the polyphenols found in EVOO, the European Food Safety Authority has approved the claim that polyphenols offer protection against peroxidation of LDL (low-density lipoprotein) cholesterol at a minimal dose of 5 mg/kg/day,8 which is the equivalent of X g or X ml of Liviana EVOO.

How to

Contrary to popular belief, olive oil can be used for cooking. That being said, to optimize the intake of beneficial phenolic compounds, you should mainly aim to include ‘raw’ (uncooked) EVOO in your eating pattern.

Here are some tips on how to include EVOO in your daily eating pattern:

  • Keep a bottle of EVOO at work to dress salads
  • Make delicious homemade vinaigrettes
  • Drizzle it over grain dishes or soups as a finishing oil
  • Toss veggies in EVOO before roasting them
  • Drizzle it over roasted veggies after cooking
  • Replace the mayo with EVOO for tuna and chicken salads
  • Deconstruct a normal sandwich and use the oil to dress the salad and for dipping the bread
  • Drizzle it over toast instead of butter
  • Sauté veggies and meat in it
  • Replace vegetable oil or butter with olive oil when baking (see the below conversion chart)
  • Use it to grease the pan for baked goods instead of butter or margarine
Butter or MargarineOlive Oil
1 teaspoon¾ teaspoon
1 tablespoon2 ¼ teaspoons
2 tablespoons1 ½ tablespoons
¼ cup3 tablespoons
⅓ cup¼ cup
½ cup¼ cup + 2 tablespoons
⅔ cup½ cup
¾ cup½ cup + 1 tablespoon
1 cup¾ cup


  1. Yubero-Serrano EM, Lopez-Moreno J, Gomez-Delgado F, Lopez-Miranda J. 2019. Extra virgin olive oil: More than a healthy fat. European Journal of Clinical Nutrition, 72(Suppl 1):8-17.
  2. Dinu M, Pagliai G, Casini A & Sofi F. 2017. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. European Journal of Clinical Nutrition. doi:10.1038/ejcn.2017.58
  3. George, ES, Marshall, S, Mayr, H, Trakman G, et al. 2018. The effect of high-polyphenol extra virgin olive oil on cardiovascular risk factors: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition, 59(17):2772-2795. 
  4. Davis C, Bryan J, Hodgson & Murphy K. 2015. Definition of the Mediterranean diet: A literature review. Nutrients, 7, 9139-9153. doi:10.3390/nu7115459
  5. Martínez-González MA, Salas-Salvadó J, Estruch R, Corella D, Fitó M & Ros E. 2015. Benefits of the Mediterranean Diet: Insights from the PREDIMED study. Progress in Cardiovascular Diseases, 58:50-60.
  6. Itsiopoulos C, Kucianski T, Mayr HL, van Gaal WJ, et al. 2018. The AUStralian MEDiterranean Diet Heart Trial (AUSMED Heart Trial): A randomized clinical trial in secondary prevention of coronary heart disease in a multiethnic Australian population: Study protocol. American Heart Journal, 203, 4-11.
  7. George ES, Kucianski T, Mayr HL, Moschonis G, et al. 2018. A Mediterranean Diet model in Australia: Strategies for translating the traditional Mediterranean Diet into a multicultural setting. Nutrients, 10:465. doi:10.3390/nu10040465
  8. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). 2011. Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL-cholesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), “anti-inflammatory properties” (ID 1882), “contributes to the upper respiratory tract health” (ID 3468), “can help to maintain a normal function of gastrointestinal tract” (3779), and “contributes to body defences against external agents” (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4):2033 [25 pp.]. doi:10.2903/j.efsa.2011.2033. Available online:

Nicola Royce
Registered Dietitian, Postgrad. Dipl. Diabetes

Liviana™ Launches CBD-Infused Speciality Premium Honeys

Liviana is pleased to announce the launch of its CBD infused honeys

Institute of Biomedical Research (OTCBB:MRES)

CAPE TOWN, WESTERN CAPE, SOUTH AFRICA, October 19, 2022 / — Liviana™ Launches CBD-Infused Speciality Premium Honeys

Institute of Biomedical Research (OTC PINK: MRES) (“M2Bio Sciences” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update:

Liviana™ is delighted to announce the launch of its premium, organic CBD-infused raw honey range.

“Over a year’s worth of development and testing has gone into these honeys. The Liviana™ team has worked tirelessly in creating the very best CBD-infused honeys on the market. Consuming honey everyday can benefit your health in numerous ways, just like CBD, which is why I add a teaspoon of our honey into everything I make for my family” – Michael Sachar, CEO of M2Bio Food and Beverage.

The honeys are infused with pharmaceutical-grade broad-spectrum CBD, imported from Colorado, USA. They are free from psychoactive agents and do not have any intoxicating effects. Our honeys are ethically sourced and contain no additives or preservatives

Alfalfa CBD-Infused Raw Honey

Derived from beautiful Alfalfa blossoms found in the Swartberg and Outeniqua mountains, this delicate honey has a subtle taste with sweet vanilla undertones and a floral finish.

Wild Blossom CBD-Infused Raw Honey

Originating from the majestic Swartberg and Outeniqua mountains, this amber honey has a distinctively bold taste with hints of black cherry.

About Institute of Biomedical Research Corp./ DBA M2Bio Sciences

Institute of Biomedical Research Corp, is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, and Liviana™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “MRES”.

Publicly traded company (OTC Pink:MRES)



Forward-Looking Statements:
Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

Jeff Robinson
M2Bio Sciences Food and Beverage (Pty) Ltd
+27 72 333 2148
email us here
Visit us on social media: